Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients

• Julie Refardt,
• Maria J. Klomp,
• Peter M. vanKoetsveld,
• Fadime Dogan,
• Mark Konijnenberg,
• Tessa Brabander,
• Richard A. Feelders,
• Wouter W. deHerder,
• Leo J. Hofland,
• Johannes Hofland

Affiliations

Julie Refardt

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Maria J. Klomp

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Peter M. vanKoetsveld

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Fadime Dogan

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Mark Konijnenberg

ENETS Center of Excellence, Department of Radiology & Nuclear Medicine Erasmus Medical Center Rotterdam The Netherlands

Tessa Brabander

ENETS Center of Excellence, Department of Radiology & Nuclear Medicine Erasmus Medical Center Rotterdam The Netherlands

Richard A. Feelders

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Wouter W. deHerder

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Leo J. Hofland

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

Johannes Hofland

ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands